Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283322 · ClinicalTrials.gov registry record
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 185
- Enrollment target
NCT00283322: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT00283322 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 185 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283322 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
Study Summary
Intensive care unit patients have multiple risk factors for venous thromboembolism. Venous thromboembolism leads to significant morbidity and can be fatal. Unfractionated heparin and low molecular weight heparin are commonly used to prevent venous thromboembolism. Heparin induced thrombocytopenia, an untoward consequence of exposure to heparin, is an immune disorder that may develop in patients treated with heparin products. Determining the prevalence of heparin induced thrombocytopenia and its relationship to preventive and therapeutic heparin and low molecular weight heparin will help clinicians more appropriately choose methods of venous thromboembolism prophylaxis and treatment in the critically ill, ICU population. The objective of this study is to determine the prevalence of heparin-induced antibodies on admission to the ICU and the development of new heparin-antibodies during the first week of hospitalization.
Interventions
- OTHER blood samples (2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-05 |
What the finished NCT00283322 record still lists
NCT00283322 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which blood samples (2) is the first listed.
NCT00283322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00283322 about?
NCT00283322 is a clinical study titled "Heparin Antibodies in Intensive Care Unit Patients (HAICU)". Intensive care unit patients have multiple risk factors for venous thromboembolism. Venous thromboembolism leads to significant morbidity and can be fatal. Unfractionated heparin and low molecular weight heparin are commonly used to prevent venous thromboembolism. Heparin induced thrombocytopenia, a...
What is the current status of trial NCT00283322?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2004-11. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00283322?
The interventions under investigation include: blood samples (2) (OTHER).
Who is sponsoring clinical trial NCT00283322?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia